> top > docs > PMC:6986229 > spans > 8587-10100 > annotations

PMC:6986229 / 8587-10100 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
127 37-43 Species denotes People Tax:9606
128 117-130 Disease denotes HIV infection MESH:D015658
129 181-194 Disease denotes HIV infection MESH:D015658
134 316-322 Species denotes people Tax:9606
135 383-386 Species denotes men Tax:9606
136 405-408 Species denotes men Tax:9606
137 413-419 Species denotes people Tax:9606
140 1010-1014 Gene denotes JAMA Gene:50848
141 1116-1137 Disease denotes infections within HIV MESH:D015658
145 1191-1197 Species denotes people Tax:9606
146 1255-1264 Chemical denotes tenofovir MESH:C096918
147 1269-1282 Chemical denotes emtricitabine MESH:C122114

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T71 0-36 Sentence denotes Pre-exposure prophylaxis against HIV
T72 37-258 Sentence denotes People who are taking antiretroviral drugs to protect themselves from acquiring HIV infection because they are considered to be at high risk of HIV infection are also at high risk of other sexually transmitted infections.
T73 259-515 Sentence denotes Pre-exposure prophylaxis (PrEP) is given to HIV-negative people with a higher-than-average risk of contracting HIV, such as men who have sex with men and people who inject drugs, sero-discordant couples, and young adolescents in certain parts of the world.
T74 516-764 Sentence denotes These services could be an ideal place to test for, prevent and treat HIV, as well as other sexually transmitted infections, according to a global study led by Monash University in Australia and supported by WHO that was published in December 2019.
T75 765-984 Sentence denotes The Melbourne Sexual Health Centre and WHO worked with a team of researchers to conduct a global systematic review evaluating the prevalence and incidence of sexually transmitted infections among individuals using PrEP.
T76 985-1149 Sentence denotes The review, published in JAMA Network Open, highlighted the limited focus and investment in the management of sexually transmitted infections within HIV programmes.
T77 1150-1222 Sentence denotes Since 2015, WHO has recommended PrEP for people at substantial HIV risk.
T78 1223-1283 Sentence denotes It consists of a combination of tenofovir and emtricitabine.
T79 1284-1305 Sentence denotes http://bit.ly/38786yk
T80 1306-1319 Sentence denotes Looking ahead
T81 1320-1335 Sentence denotes 3 – 8 February.
T82 1336-1403 Sentence denotes WHO Executive Board Meeting, WHO headquarters, Geneva, Switzerland.
T83 1404-1421 Sentence denotes 24 – 26 February.
T84 1422-1513 Sentence denotes First Global Technical Partnership Meeting on Antimicrobial Stewardship, Bangkok, Thailand.